The medical community should be willing to experiment with AI systems that make autonomous clinical decisions, rather than insisting physicians always have the final say, according to a Sept. 8 essay advocating for autonomous AI physicians Emanuel Khosla believe could meaningfully improve care.
Who Is Behind This Autonomous AI Physicians Emanuel Khosla Argument
Ezekiel Emanuel, MD, PhD, and venture capitalist Vinod Khosla wrote the piece for The Atlantic. Dr. Emanuel is an oncologist, bioethicist and vice provost for global initiatives at the University of Pennsylvania. Mr. Khosla is an entrepreneur, technologist and founder of venture capital firm Khosla Ventures.
The Essay’s Origins and a Disclosed Financial Interest
The essay expands on an Aug. 17 commentary the two published in JAMA, co-written with Abe Baker-Butler, also of the University of Pennsylvania, and Neal Khosla, Vinod Khosla’s son and CEO of AI virtual care company Curai Health. Vinod Khosla disclosed in the Atlantic piece that he has invested in the virtual primary care startup, co-founded by his son, in which physicians supervise AI assistants.
The Core Case Behind This Autonomous AI Physicians Emanuel Khosla Argument
The authors argue that much of modern medicine, managing hypertension, determining cancer treatment, addressing chemotherapy side effects, follows algorithmic steps AI can execute reliably. Despite their best intentions, physicians can easily make mistakes carrying out these steps; the authors noted up to 15% of Americans are misdiagnosed annually, contributing to tens of thousands of preventable deaths.
The Supporting Evidence Cited
Dr. Emanuel and Vinod Khosla point to a study in which Google’s Articulate Medical Intelligence Explorer outperformed physicians at eliciting patient information, a 2023 trial in which autonomous AI adjusted insulin doses for Type 2 diabetes patients faster than physicians did, and a 2025 review of 52 studies that found physician-AI hybrid teams did not outperform AI alone. The latter study, they argue, undercuts the common argument that keeping a physician in the loop is inherently safer.
Addressing the Human Connection Concern Within This Autonomous AI Physicians Emanuel Khosla Essay
Another common concern is that AI can’t replace the human connection of medicine. However, Dr. Emanuel and Vinod Khosla argue that physicians can also come across as robotic themselves and fail to develop deep, trusting relationships with patients. They cited a Gallup survey in which 21% of respondents said they turned to AI after feeling dismissed by a healthcare provider.
What the Authors Say Should Happen Instead of Strict Oversight
Rather than limiting progress with strict physician oversight, the authors argue the field should focus on resolving the open questions autonomous AI raises: how to design ethical, real-world testing for these models, how regulators and professional bodies should oversee them, and how medical education needs to change so physicians can focus on the skills only humans bring.
The AMA’s Opposing Framework Within This Autonomous AI Physicians Emanuel Khosla Debate
The authors cited the American Medical Association’s opposition to their JAMA commentary. AMA’s own position, laid out in an Aug. 18 framework developed with the Digital Medicine Society, emphasizes physician decision-making authority. The framework identifies five “enduring responsibilities” physicians must retain as AI expands in medicine, including preserving human connection, demonstrating clinical judgment and stewarding safe AI integration.
A More Receptive Position From the American College of Physicians
Even so, the authors concede the medical establishment isn’t uniformly opposed to loosening the reins. They cite a position paper the American College of Physicians published last week that states “fully autonomous AI is possible,” though the group recommends limiting its use to low-risk, low-complexity decisions with a clinician available to step in.
The Authors’ Closing Argument
“Doctors have been presented with a powerful tool that has the potential to improve care for millions of people. It’s their duty not to stand in the way,” they wrote, framing physician resistance to autonomous AI as itself a kind of ethical failure rather than appropriate caution.
What This Autonomous AI Physicians Emanuel Khosla Debate Means Going Forward
Given the sharp divide between this essay’s call for autonomous AI experimentation and the AMA’s five enduring physician responsibilities framework, health systems and regulators will likely need to navigate a genuinely contested professional landscape rather than a clear consensus as autonomous clinical AI tools continue advancing. Given Vinod Khosla’s disclosed financial stake in a company whose model, physician-supervised AI assistants, sits adjacent to but distinct from the fully autonomous systems the essay advocates for, readers evaluating this argument should weigh that commercial interest alongside the clinical evidence cited.
What to Watch Going Forward
As this debate continues playing out across JAMA, The Atlantic, and professional medical association statements, industry observers will likely watch whether the American College of Physicians’ more permissive stance on low-risk autonomous AI use gains broader traction among other specialty societies, or whether the AMA’s emphasis on physician authority remains the dominant professional position. Given the cited 2025 review finding physician-AI hybrid teams did not outperform AI alone, this autonomous AI physicians Emanuel Khosla debate may increasingly hinge on how regulators and professional bodies respond to evidence that appears to challenge the assumption that human oversight always improves AI-assisted clinical outcomes.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
